Cargando…
Minimization of Hypoglycemia as an Adverse Event During Insulin Infusion: Further Refinement of the Yale Protocol
Background: The management of hyperglycemia in the intensive care unit has been a controversial topic for more than a decade, with target ranges varying from 80–110 mg/dL to <200 mg/dL. Multiple insulin infusion protocols exist, including several computerized protocols, which have attempted to ac...
Autores principales: | Marvin, Michael R., Inzucchi, Silvio E., Besterman, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991569/ https://www.ncbi.nlm.nih.gov/pubmed/27257910 http://dx.doi.org/10.1089/dia.2016.0101 |
Ejemplares similares
-
Yale insulin protocol infusion in sepsis patients
por: Oliveira, S
Publicado: (2011) -
Severe hypoglycemia with trastuzumab: An unseen adverse event
por: Amrith, B. P., et al.
Publicado: (2019) -
Continuous Subcutaneous Insulin Infusion in Children: A Pilot Study Validating a Protocol to Avoid Hypoglycemia at Initiation
por: Manousaki, Despoina, et al.
Publicado: (2017) -
The Yale Cellos,
Publicado: (1987) -
Biotechnology at Yale.
por: Shiao, S.
Publicado: (2001)